CBMX: Summary for CombiMatrix Corporation - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 7:13am EST - Canadian Markets open in 2 hours and 17 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

CombiMatrix Corporation (CBMX)

On Feb 9: 6.43 USD 0.00 (0.00%)

MORE ON CBMX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CombiMatrix Corporation (NGM:CBMX) Delayed quote data

Last Trade:	6.43 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	6.43
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	5.41 - 10.05
Volume:	0
Avg Vol (3m):	20,057.1
Market Cap:	48.68M
P/E (ttm):	N/A
EPS (ttm):	-2.09
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CBMX to Portfolio

Download Data

HEADLINES

•	COMBIMATRIX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Fri, Jan 29)

•	COMBIMATRIX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
	EDGAR Online (Mon, Jan 25)

•	COMBIMATRIX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
	EDGAR Online (Fri, Jan 15)

•	COMBIMATRIX CORP Financials
	EDGAR Online Financials (Thu, Nov 19)

•	COMBIMATRIX CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	COMBIMATRIX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
	EDGAR Online (Thu, Nov 12)

•	New Star Analyst Rankings for CombiMatrix Corporation
	StarMine (Thu, Nov 12)

•	COMBIMATRIX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Mon, Oct 5)

•	COMBIMATRIX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
	EDGAR Online (Mon, Sep 14)

•	COMBIMATRIX CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Aug 14)

More Headlines for CBMX...

ANALYST

EPS Est (next year) () :	N/A
EPS Est (in 2 years) () :	N/A
Avg Rec (current)*:	N/A
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

CombiMatrix Corporation develops and sells proprietary technologies, products, and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology research, defense, and homeland security.

Full Company Profile

Add to Portfolio

Email to a Friend

•